Hepatic Venoocclusive Disease with Immunodeficiency Latest Advances

An excerpt of the European Association for the Study of the Liver's clinical practice guidelines on liver vascular diseases in 2025

Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology

Published: May 28, 2026

Defibrotide-Responsive Cutaneous Endothelial Injury Following Allogeneic Hematopoietic Stem Cell Transplant: A Case Report.

Journal: Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation

Published: May 13, 2026

Recent advances in trastuzumab and its antibody-drug conjugates-related liver injury.

Journal: Expert opinion on drug safety

Published: May 12, 2026

Massive bleeding from a Bricker ileal conduit during FOLFIRINOX therapy in noncirrhotic portal hypertension: suspected oxaliplatin-associated sinusoidal injury and presumed irinotecan-associated conduit mucositis: a case report.

Journal: BMC urology

Published: April 11, 2026

Retrospective analysis of inotuzumab-associated hepatotoxicity in adult patients with B-cell acute lymphoblastic leukemia: Expanding the Spectrum of calicheamicin syndrome.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: April 10, 2026

[18F]FAPI PET/MR imaging in a patient with liver metastasis of breast cancer complicated by hepatic sinusoidal obstruction syndrome.

Journal: European journal of nuclear medicine and molecular imaging

Published: April 01, 2026

Impact of Concurrent Graft-versus-Host Disease on Long-Term Survival in Critically Ill Patients Following Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies.

Journal: Transplantation and cellular therapy

Published: March 25, 2026

Case report:Maribavir for refractory CMV infection in 2 pediatric HSCT recipients.

Journal: Diagnostic microbiology and infectious disease

Published: March 23, 2026

Chronic arsenic poisoning from a realgar-containing traditional medicine causing hepatic veno-occlusive disease and polyserositis: a case report.

Journal: Journal of medical case reports

Published: March 19, 2026

Serum Syndecan-1: a potent prognostic biomarker for transplant outcomes.

Journal: Frontiers in medicine

Published: March 11, 2026

Assessment of Risks and Outcomes of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Allogeneic Stem Cell Transplant Recipients Including Potentially Undiagnosed Cases-A Multicenter Canadian Study.

Journal: Current oncology (Toronto, Ont.)

Published: March 01, 2026

Incidence, Risk Factors and Outcomes of Sinusoidal Obstruction Syndrome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation With PTCy-Based Prophylaxis.

Journal: Transplantation and cellular therapy

Published: February 13, 2026

Hepatic Venoocclusive Disease with Immunodeficiency Latest Advances

Find the Latest Research About Hepatic Venoocclusive Disease with Immunodeficiency

An excerpt of the European Association for the Study of the Liver's clinical practice guidelines on liver vascular diseases in 2025

An excerpt of the European Association for the Study of the Liver's clinical practice guidelines on liver vascular diseases in 2025

Defibrotide-Responsive Cutaneous Endothelial Injury Following Allogeneic Hematopoietic Stem Cell Transplant: A Case Report.

Defibrotide-Responsive Cutaneous Endothelial Injury Following Allogeneic Hematopoietic Stem Cell Transplant: A Case Report.

Recent advances in trastuzumab and its antibody-drug conjugates-related liver injury.

Recent advances in trastuzumab and its antibody-drug conjugates-related liver injury.

Massive bleeding from a Bricker ileal conduit during FOLFIRINOX therapy in noncirrhotic portal hypertension: suspected oxaliplatin-associated sinusoidal injury and presumed irinotecan-associated conduit mucositis: a case report.

Massive bleeding from a Bricker ileal conduit during FOLFIRINOX therapy in noncirrhotic portal hypertension: suspected oxaliplatin-associated sinusoidal injury and presumed irinotecan-associated conduit mucositis: a case report.

Retrospective analysis of inotuzumab-associated hepatotoxicity in adult patients with B-cell acute lymphoblastic leukemia: Expanding the Spectrum of calicheamicin syndrome.

Retrospective analysis of inotuzumab-associated hepatotoxicity in adult patients with B-cell acute lymphoblastic leukemia: Expanding the Spectrum of calicheamicin syndrome.

[18F]FAPI PET/MR imaging in a patient with liver metastasis of breast cancer complicated by hepatic sinusoidal obstruction syndrome.

[18F]FAPI PET/MR imaging in a patient with liver metastasis of breast cancer complicated by hepatic sinusoidal obstruction syndrome.

Impact of Concurrent Graft-versus-Host Disease on Long-Term Survival in Critically Ill Patients Following Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies.

Impact of Concurrent Graft-versus-Host Disease on Long-Term Survival in Critically Ill Patients Following Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies.

Case report:Maribavir for refractory CMV infection in 2 pediatric HSCT recipients.

Case report:Maribavir for refractory CMV infection in 2 pediatric HSCT recipients.

Chronic arsenic poisoning from a realgar-containing traditional medicine causing hepatic veno-occlusive disease and polyserositis: a case report.

Chronic arsenic poisoning from a realgar-containing traditional medicine causing hepatic veno-occlusive disease and polyserositis: a case report.

Serum Syndecan-1: a potent prognostic biomarker for transplant outcomes.

Serum Syndecan-1: a potent prognostic biomarker for transplant outcomes.

Assessment of Risks and Outcomes of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Allogeneic Stem Cell Transplant Recipients Including Potentially Undiagnosed Cases-A Multicenter Canadian Study.

Assessment of Risks and Outcomes of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Allogeneic Stem Cell Transplant Recipients Including Potentially Undiagnosed Cases-A Multicenter Canadian Study.

Incidence, Risk Factors and Outcomes of Sinusoidal Obstruction Syndrome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation With PTCy-Based Prophylaxis.

Incidence, Risk Factors and Outcomes of Sinusoidal Obstruction Syndrome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation With PTCy-Based Prophylaxis.